(2-((3-Morpholinopropyl)amino)-1H-benzo[d]imidazol-6-yl)Methanol结构式
|
常用名 | (2-((3-Morpholinopropyl)amino)-1H-benzo[d]imidazol-6-yl)Methanol | 英文名 | (2-((3-Morpholinopropyl)amino)-1H-benzo[d]imidazol-6-yl)Methanol |
---|---|---|---|---|
CAS号 | 857070-67-8 | 分子量 | 290.36100 | |
密度 | N/A | 沸点 | N/A | |
分子式 | C15H22N4O2 | 熔点 | N/A | |
MSDS | N/A | 闪点 | N/A |
英文名 | [2-(3-morpholin-4-ylpropylamino)-3H-benzimidazol-5-yl]methanol |
---|---|
英文别名 | 更多 |
分子式 | C15H22N4O2 |
---|---|
分子量 | 290.36100 |
精确质量 | 290.17400 |
PSA | 76.64000 |
LogP | 0.54920 |
~84% (2-((3-Morpholi... 857070-67-8 |
文献:Bonfanti, Jean-Francois; Meyer, Christophe; Doublet, Frederic; Fortin, Jerome; Mueller, Philippe; Queguiner, Laurence; Gevers, Tom; Janssens, Peggy; Szel, Heidi; Willebrords, Rudy; Timmerman, Philip; Wuyts, Koen; Van Remoortere, Pieter; Janssens, Frans; Wigerinck, Piet; Andries, Koen Journal of Medicinal Chemistry, 2008 , vol. 51, # 4 p. 875 - 896 |
~81% (2-((3-Morpholi... 857070-67-8 |
文献:TIBOTEC PHARMACEUTICALS LTD. Patent: WO2005/58871 A1, 2005 ; Location in patent: Page/Page column 42-43 ; |
(2-((3-morpholinopropyl)amino)-1H-benzo[d]imidazol-6-yl)methanol |
[2-(3-morpholin-4-ylpropylamino)-3H-benzoimidazol-5-yl]methanol |
1H-Benzimidazole-5-methanol,2-[[3-(4-morpholinyl)propyl]amino] |